Merck & Co., Inc. TRDA Holdings History
Number of Shares
1.74 Mil
Current Holdings Value*
$15.73 Mil
% of Portfolio
9.57%
Total Estimate Gain
$-19.75 Mil
% of Total Estimate Gain
-62.53%
Merck & Co., Inc.'s Entrada Therapeutics Inc Holding Summary
As of 2025-03-31, Merck & Co., Inc. held 1.74 Mil shares of Entrada Therapeutics Inc(TRDA), totaling $15.73 Mil. This investment constitutes 9.57% of their stock portfolio, and Merck & Co., Inc. now holds 4.58% of the outstanding Entrada Therapeutics Inc(TRDA) stock.
The initial trade took place in 2024Q4. Based on historical transaction data and TRDA's current price of $6.80, Merck & Co., Inc.'s estimated gain on his TRDA holdings is $-19.75 Mil, reflecting a -62.53% gain to date.
Merck & Co., Inc. TRDA ($6.80) Holding Chart
Merck & Co., Inc. TRDA ($6.80) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers